<3.3-Diethoxy-2-n-propylcyclopentyl>-essigsaeuremethylester | 42186-38-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: <3.3-Diethoxy-2-n-propylcyclopentyl>-essigsaeuremethylester
• 英文别名: Methyl 2-(3,3-diethoxy-2-propylcyclopentyl)acetate；methyl 2-(3,3-diethoxy-2-propylcyclopentyl)acetate
• CAS: 42186-38-9
• 化学式: C₁₅H₂₈O₄
• 分子量: 272.385
• InChiKey: BVWPPSRNJNHHSW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  19
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Process for the preparation of cis-alpha,beta substituted cyclopentanones
  申请人：FIRMENICH SA

  公开号：US11339113B2

  公开（公告）日：2022-05-24

  Described herein is a process for the preparation of a mixture of compounds of formula having a weight ratio of the cis-diastereomers to trans-diastereoisomers higher than 1:1, where R1 represents a C1-8 alkyl group, a C2-8 alkenyl group or a C2-8 alkynyl group, each optionally substituted with one or two of a C1-4 alkyl alkoxy ether group and/or a C1-4 alkyl carboxylester group and R2 represents a C1-6 alkyl, a C2-6 alkenyl or a C2-6 alkynyl group, each optionally substituted with a C1-4 alkyl alkoxy ether group, a carboxylic acid group or a C1-4 alkyl carboxylester group and compounds suitable in the process.

  本文描述了一种制备式化合物混合物的工艺，该混合物的化学式为 顺式-非对映异构体与反式-非对映异构体的重量比高于 1：其中 R1 代表 C1-8 烷基、C2-8 烯基或 C2-8 烷炔基，每个基团可选择被一个或两个 C1-4 烷基烷氧基醚基和/或 C1-4 烷基羧基酯基取代；R2 代表 C1-6 烷基、C2-6 烯基或 C2-6 烷炔基，每个基团可选择被一个 C1-4 烷基烷氧基醚基、一个羧基或一个 C1-4 烷基羧基酯基取代。
• PROCESS FOR THE PREPARATION OF CIS-ALPHA,BETA SUBSTITUTED CYCLOPENTANONES
  申请人：Firmenich SA

  公开号：EP3823954A1

  公开（公告）日：2021-05-26
• [EN] PROCESS FOR THE PREPARATION OF CIS-ALPHA,BETA SUBSTITUTED CYCLOPENTANONES<br/>[FR] PROCÉDÉ DE PRÉPARATION DE CYCLOPENTANONES À SUBSTITUTION CIS-ALPHA,BÊTA
  申请人：FIRMENICH & CIE

  公开号：WO2020127094A1

  公开（公告）日：2020-06-25

  The present invention relates to a process for the preparation of a mixture of compounds of formula (I), (I) having a weight ratio of the cis-diastereomers to trans-diastereoisomers higher than 1:1, wherein R1 represents a C1-8 alkyl group, a C2-8 alkenyl group or a C2-8 alkynyl group, each optionally substituted with one or two of a C1-4 alkyl alkoxy ether group and/or a C1-4 alkyl carboxylester group and R2 represents a C1-6 alkyl, a C2-6 alkenyl or a C2-6 alkynyl group, each optionally substituted with a C1-4 alkyl alkoxy ether group, a carboxylic acid group or a C1-4 alkyl carboxylester group and compounds suitable in said process.